This dissertation advances organoid technology along two complementary axes toward reproducible, mechanistically interpretable platforms for modeling tissue physiology and toxicity.
Chapter 1 addresses a central limitation of organoid culture: its de...
This dissertation advances organoid technology along two complementary axes toward reproducible, mechanistically interpretable platforms for modeling tissue physiology and toxicity.
Chapter 1 addresses a central limitation of organoid culture: its dependence on Matrigel, an undefined, batch-variable, and poorly tunable matrix. By engineering a photo-crosslinkable hyaluronic acid–collagen (HA–collagen) hydrogel through riboflavin phosphate–mediated blue-light irradiation, rapid and uniform gelation was achieved with spatiotemporal control over crosslink density. Systematically varying the collagen-to-HA ratio established quantitative structure– function relationships linking matrix composition to stiffness, viscosity, stress relaxation, and pore–fibril architecture. The optimal condition (Col4HA1) reproduced Matrigel-like growth while maintaining a mechanically permissive window that preserved stemness (Lgr5, Sox9), differentiation (Villin), and proper E-cadherin/β-catenin–mediated epithelial polarity. Notably, Col4HA1 sustained homeostatic Lgr5 expression throughout passaging, positioning this defined hydrogel as a tunable, reproducible alternative to Matrigel and as a foundation for organ-specific microenvironment design.
Chapter 2 uses murine liver organoids to dissect how carbonyl stress is transduced into hepatocellular injury. The synthetic glucocorticoid dexamethasone (Dex) sensitized hepatocytes to glyoxal (GO)–induced carbonyl stress. GO+Dex co-exposure markedly increased CML accumulation, RAGE expression, and ERK/JNK phosphorylation, accompanied by glutathione (GSH) depletion and a decreased GSH/GSSG ratio. Transcriptomic analysis revealed a UPR-associated signature in which CHAC1 acted as a key effector: GO+Dex elevated Chac1 and Ddit3 expression and enhanced PERK–eIF2α phosphorylation. GSH supplementation and ISRIB blunted these responses and reduced CML accumulation and mitochondrial ROS, with ISRIB additionally lowering RAGE expression and partially restoring respiratory function. These results delineate a mechanism in which glucocorticoid exposure converges with GSH depletion and glyoxal-induced carbonyl stress on a CHAC1-associated PERK–eIF2α integrated stress response, driving redox collapse and mitochondrial injury. Although the engineered hydrogel and the redox-toxicity model were developed in different organoid systems, they constitute two complementary components of a single objective: advancing organoid technology through the design of a defined extracellular microenvironment and the mechanistic dissection of cellular stress responses.
Chapter 1 holds the biological readout constant to define and optimize the matrix, whereas Chapter 2 holds the culture system constant to isolate stress mechanisms, together reflecting a one-variable-at-a-time strategy. The unifying theme is reproducibility: Chapter 1 establishes a chemically defined, organ-tunable microenvironment that removes the batch variability inherent to Matrigel, while Chapter 2 exemplifies the mechanistic redox and toxicity analysis for which such a controlled substrate is ultimately required. Because the present stress model was, of necessity, established in the conventional Matrigel-based system, re-optimizing the defined hydrogel for liver organoids and re-evaluating the GSH/ISR– mitochondrial axis within it represents the logical next step—one through which defined microenvironment engineering and quantitative stress-response readouts can be integrated into a single reproducible platform for disease modeling and toxicity assessment.